Procept BioRobotics :
PRCT
PRCT
Stock Data
$24.63
$0.59 (2.45%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Procept BioRobotics Corp is a pioneering force in the field of surgical robotics, specifically targeting urology. With its flagship AquaBeam Robotic System, the company offers a cutting-edge, minimally invasive solution for treating benign prostatic hyperplasia (BPH), a common urological condition. Based in San Jose, California, and established in 2007, Procept BioRobotics is dedicated to improving the quality of life for men experiencing lower urinary tract symptoms through its innovative Aquablation therapy.